The researchers found that this treatment was beneficial in reducing pain while also improving quality of life. “Medical cannabis treatment with the Syqe Inhaler demonstrated overall long-term pain reductions, quality of life improvements, and opioid-sparing effects in a cohort of patients with chronic pain, using just a fraction of the amount of MC [medical cannabis] compared with other modes of delivery by inhalation. These outcomes were accompanied by a lower rate of AEs [adverse events] and almost no AE reports during a long-term steady-state follow-up. Additional follow-ups in a larger population is warranted to corroborate our findings,” the authors concluded.
A point-by-point look at SAM’s New York report finds a familiar pattern: selective data, overstated…
"The War on Drugs" is a 12-track musical history project chronicling America's century-long crusade against…
My courageous struggle to stay high through the marijuana dark ages of the ‘80s and…
When I first started writing this, I thought it would be a quick explainer of…
Grenada’s reform is building regional momentum, but Bermuda’s path runs straight into a UK veto,…
The hemp boom moved fast. In the years following the 2018 Farm Bill, thousands of…